José Manuel Vagace Valero

Full Professor of University

Universidad de Extremadura

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (5)

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Massimo Bogliolo

Tenured lecturer - Serra-Hunter program

University of Barcelona

SPAIN

View details

Isabel Badell

Professor

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

José Manuel Vagace Valero

Research Interests

Explore related searches

Contact this professor

Articles (5)

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies

C>A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: A non-deletional mutation or polymorphism?

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

Collaborators (2)

Massimo Bogliolo

Isabel Badell

Make your next move.

José Manuel Vagace Valero

Research Interests

Explore related searches

Contact this professor

Articles (5)

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies

C&gt;A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: A non-deletional mutation or polymorphism?

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

Collaborators (2)

Massimo Bogliolo

Isabel Badell

Make your next move.

C>A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: A non-deletional mutation or polymorphism?